Prelude Capital Management, LLC Mckesson Corp Transaction History

Prelude Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$346.68 - $397.58 $373,721 - $428,591	1,078 New	1,078 $404,000
Q1 2022 May 16, 2022	SELL	$244.61 - $310.48 $640,144 - $812,526	-2,617 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.21 - $248.9 $518,715 - $651,371	2,617 New	2,617 $651,000
Q3 2021 Nov 15, 2021	SELL	$188.42 - $208.66 $1.02 Million - $1.13 Million	-5,409 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$184.89 - $202.68 $1 Million - $1.1 Million	5,409 New	5,409 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$143.79 - $183.66 $429,500 - $548,592	-2,987 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$140.89 - $159.9 $265,577 - $301,411	1,885 Added 171.05%	2,987 $445,000
Q2 2020 Aug 14, 2020	BUY	$125.49 - $164.68 $92,737 - $121,698	739 Added 203.58%	1,102 $169,000
Q1 2020 May 15, 2020	SELL	$115.75 - $170.96 $4,630 - $6,838	-40 Reduced 9.93%	363 $49,000
Q4 2019 Feb 14, 2020	BUY	$130.23 - $153.27 $52,482 - $61,767	403 New	403 $56,000
Q1 2019 May 15, 2019	SELL	$111.86 - $136.3 $272,826 - $332,435	-2,439 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$108.23 - $136.84 $263,972 - $333,752	2,439 New	2,439 $269,000

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.